{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:40:13Z","timestamp":1794278413190,"version":"4.9.0"},"reference-count":34,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>PI\u2010RADS 3 lesions represent a diagnostic \u201cgray zone\u201d in which biopsy decision\u2010making is particularly challenging, with reported clinically significant prostate cancer (csPCa) detection rates ranging from 13% to 50%. This study evaluated the predictive value of the systemic immune\u2010inflammation index (SII), neutrophil\u2010to\u2010lymphocyte ratio (NLR), and platelet\u2010to\u2010lymphocyte ratio (PLR)\u2014alone and in combination with PSA density (PSAD) and PI\u2010RADS score\u2014for the detection of prostate cancer (PCa) and csPCa, with a specific focus on the PI\u2010RADS 3 subgroup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this two\u2010center retrospective observational study, 982 patients who underwent prostate biopsy between 2020 and 2025 were included. csPCa was defined as ISUP Grade Group \u2265\u20092. Univariable and multivariable logistic regression analyzes were performed to identify independent predictors of PCa and csPCa. In the PI\u2010RADS 3 subgroup (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009251), two predictive models were compared using receiver operating characteristic analysis and the DeLong test: Model 1 (age, free\/total PSA ratio, PSAD) and Model 2 (Model 1\u2009+\u2009SII\u2009+\u2009NLR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 982 patients, 188 (19.1%) were diagnosed with PCa and 150 (15.3%) with csPCa. In the overall cohort, NLR\u2009\u2265\u20092.11 was independently associated with csPCa (OR, 15.924; 95% CI, 2.472\u2010102.567;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), whereas SII did not retain independent significance. PLR showed an inverse association with PCa, possibly reflecting tumor\u2010related platelet dynamics. In the PI\u2010RADS 3 subgroup, SII\u2009\u2265\u2009661.37 (OR, 2.317;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039) remained an independent predictor of PCa alongside age, free\/total PSA ratio, and PSAD\u2009\u2265\u20090.20 (OR, 6.111;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013), while NLR showed borderline significance. The addition of SII and NLR to the clinical model increased the AUC from 0.795 to 0.816 in the PI\u2010RADS 3 subgroup, although this improvement did not reach statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.134).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Systemic inflammatory markers\u2014particularly SII and NLR\u2014provide complementary predictive information in the pre\u2010biopsy risk stratification of prostate cancer. SII emerged as an independent predictor of PCa specifically within the PI\u2010RADS 3 gray zone, while NLR independently predicted csPCa in the overall cohort. These routinely available, low\u2010cost parameters may serve as practical adjuncts to PSA derivatives and mpMRI in the individualization of biopsy decisions, particularly for PI\u2010RADS 3 patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pros.70210","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:30:58Z","timestamp":1781807458000},"page":"1281-1291","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hematological Inflammation Markers in the Prediction of Clinically Significant Prostate Cancer and the Individualization of Biopsy Decisions for PI\u2010RADS 3 Lesions: A Two\u2010Center Retrospective Study"],"prefix":"10.1002","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9065-6611","authenticated-orcid":false,"given":"Ali","family":"Eroglu","sequence":"first","affiliation":[{"name":"Department of Urology, University of Health Sciences \u0130zmir Tepecik Training and Research Hospital \u0130zmir T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1634-4516","authenticated-orcid":false,"given":"Cem Tugrul","family":"Gezmis","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Health Sciences \u0130stanbul Taksim Training and Research Hospital \u0130stanbul T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Arikan","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Health Sciences \u0130zmir Tepecik Training and Research Hospital \u0130zmir T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusret Can","family":"Cilesiz","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Health Sciences \u0130stanbul Taksim Training and Research Hospital \u0130stanbul T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Koras","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Health Sciences \u0130zmir Tepecik Training and Research Hospital \u0130zmir T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-1319","authenticated-orcid":false,"given":"Busra","family":"Emir","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Biostatistics \u0130zmir Katip Celebi University \u0130zmir T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Bahadir Can","family":"Balci","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Health Sciences \u0130stanbul Taksim Training and Research Hospital \u0130stanbul T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Zeynel","family":"Keskin","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Health Sciences \u0130zmir Tepecik Training and Research Hospital \u0130zmir T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.09.042"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3712"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-022-00537-2"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066327"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24762"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-017-0024-7"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.03.010"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18856"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.05.002"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04033.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1076428"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2022-0179"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.754649"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.12.004"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7248"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2017.11.001"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-021-00417-1"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0442"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.812319"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26242-7"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuroe.2021.04.006"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030820"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.164198"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.12.006"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0669-2"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101490"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74703-8"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.02.002"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2363-5"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.6781"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102071"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81965-3"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.70210","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pros.70210","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.70210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:02:28Z","timestamp":1791561748000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.70210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/pros.70210"],"URL":"https:\/\/doi.org\/10.1002\/pros.70210","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"2026-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}